Fermata Advisors, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fermata Advisors, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$383,888
+146.0%
56,702
+130.4%
0.11%
+134.8%
Q4 2022$156,035
+3.3%
24,611
+1.2%
0.05%
-6.1%
Q3 2022$151,000
-28.8%
24,311
+1.2%
0.05%
-33.8%
Q2 2022$212,000
+28.5%
24,011
+22.6%
0.07%
+19.4%
Q1 2022$165,000
-9.8%
19,586
+9.1%
0.06%
-7.5%
Q4 2021$183,000
-26.5%
17,955
+39.9%
0.07%
-39.1%
Q3 2021$249,000
+20.9%
12,830
+9.2%
0.11%
-8.3%
Q2 2021$206,00011,7500.12%
Other shareholders
INMUNE BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders